$AXDX
Accelerate Diagnostics Inc
PRICE
$1.04 ▲4.765%
Last Close
VOLUME
497,715
DAY RANGE
0.9342 - 1.08
52 WEEK
0.502 - 8.05
Key Metrics
Market Cap
72.45 M
Beta
1.31
Avg. Volume
2.15 M
Shares Outstanding
69.66 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
CEO: John Phillips
Website: acceleratediagnostics.com
HQ: 3950 S Country Club Rd Ste 470 Bldg 3-307 Tucson, 85714-2240 Arizona
Related News